Transcatheter Aortic Valve Replacement in Nonsurgical Candidates With Severe, Symptomatic Aortic Stenosis: A Cost-Effectiveness Analysis [Original Articles]

Conclusions— TAVR seems to be an effective but somewhat expensive alternative to medical management among patients with symptomatic aortic stenosis ineligible for surgery. TAVR is more cost-effective for patients with a lower burden of noncardiac disease.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Tags: Health policy and outcome research Original Articles Source Type: research